The effects upon the rabbit blood-brain barrier after intracarotid injection of two non-ionic contrast media, iopentol (a monomer) and iodixanol (a dimer) were compared. Iothalamate and iohexol were used as reference substances. 99Tcm-DTPA, 125I-HSA and Trypsin blue were used as tracers in order to demonstrate various degrees of damage to the barrier. Injection of iothalamate led to large extravasation of 99Tcm-DTPA, 125I-HSA and Trypan blue which means severe damage of the blood-brain barrier. Injection of iopentol and iohexol resulted in some extravasation of all three tracers used, whereas injection of iodixanol only led to extravasation of the small molecule tracer 99Tcm-DTPA demonstrating minor changes of the barrier. At computed tomography of the brain with intravascular contrast medium enhancement it is safer to use iodixanol than iothalamate. Iodixanol is expected to cause even less adverse effects to the brain after intraarterial injection than iopentol and iohexol.
AulieÅ.: Effect of iohexol, metrizamide and ioxaglate on the blood-brain barrier. Acta Radiol. (1980) Suppl. No. 362, p. 13.
2.
BromanT.OlssonO.: The tolerance of cerebral blood-vessels to a contrast medium of the diodrast group. Acta Radiol.30 (1948), 326.
3.
BromanT.OlssonO.: Experimental study of contrast media for cerebral angiography with reference to possible injurious effects on the cerebral blood vessels. Acta Radiol.31 (1949), 321.
4.
CailléJ.-M.BillereyJ.RenouA. M.ConstantP.: Cerebral blood volume and water extraction from cerebral parenchyma by hyperosmolar contrast media. Neuroradiology16 (1978), 579.
5.
DrayerB. P.VelajR., Bird R. and coll.: Comparative safety of intracarotid iopamidol, iothalamate meglumine and diatrizoate meglumine for cerebral angiography. Invest. Radiol.19 (1984), 212.
6.
GolmanK.: The blood-brain barrier. Effects of non-ionic contrast media with and without addition of Ca2+ and Mg2+. Invest. Radiol.14 (1979), 305.
7.
GolmanK.: Internal report. Nycomed, Oslo 1982.
8.
GonsetteR. E.: Biologic tolerance of the central nervous system to metrizamide. Acta Radiol. (1973) Suppl. No. 335, p. 25.
9.
HayakawaK.MorrisT. W.KatzbergR. W.FischerH. W.: Intravenous contrast media (CM) and opening of the blood-brain barrier (BBB) in euvolemic versus dehydrated rabbits. Invest. Radiol.19 (1984), 23.
10.
JeppssonP. G.OlinT.: Cerebral angiography in the rabbit. Lunds Universitets Årsskrift N. F. Avd 2, Bd 56, 14 (1960).
11.
JeppssonP. G.OlinT.: Cerebral distribution of contrast medium and paradoxial location of lesions of the blood-brain barrier in the rabbit. Acta Radiol. Diagnosis16 (1975), 577.
12.
JunckL.MarshallW.: Neurotoxicity of radiological contrast agents. Ann. Neurol.13 (1983), 469.
13.
KendallB. E.PullicinoP.: Intravascular contrast injection in ischaemic lesions. II. Effect on prognosis. Neuroradiology19 (1980), 241.
14.
MützelW.SpeckU.: Tolerance and biochemical pharmacology of Ioporomide. In: Contrast media in urography, angiography and computerized tomography, p. 11. Edited by TaenzerV.ZeitlerE., Georg Thieme Verlag, Stuttgart1983.
15.
PullicinoP.KendallB. E.: Contrast enhancement in ischaemic lesions. I. Relationship to prognosis. Neuroradiology19 (1980), 235.
16.
RapoportS. I.LevitanH.: Neurotoxicity of X-ray contrast media. Relation to lipid solubility and blood-brain barrier permeability. Amer. J. Roentgenol.122 (1974), 186.
17.
RapoportS. I.ThompsonH. K.BidingerJ. M.: Equi-osmolal opening of the blood-brain barrier in the rabbit by different contrast media. Acta Radiol. Diagnosis15 (1974), 21.
18.
SageM. R.: Review. Blood-brain barrier. Phenomenon of increasing importance to the imaging clinician. Amer. J. Neuroradiol.3 (1982), 127.
19.
SageM. R.WilcoxJ.EvillC. A.BennessG. T.: Comparison of blood-brain barrier disruption by intracarotid iopamidol and methylglucamine iothalamate. Amer. J. Neuroradiol.4 (1983), 893.
20.
SageM. R.WilcoxJ.EvillC. A.BennessG. T.: Comparison and evaluation of osmotic blood-brain barrier disruption following intracarotid mannitol and methylglucamine iothalamate. Invest. Radiol.17 (1982), 276.
21.
SalvesenS.: Acute intravenous toxicity of iohexol in the mouse and in the rat. Acta Radiol. (1980) Suppl. No. 362, p. 73.
22.
SalvesenS.: Acute intravenous toxicity of 2-5410-3 A (iodixanol) in male mice. Internal report. Nycomed, Oslo 1984.
23.
SkalpeI. O.AulieÅ.: The toxicity of non-ionic water-soluble contrast media in selective vertebral angiography. Neuroradiology27 (1985), 77.
24.
SkinnemoenK.: Internal report. Nycomed, Oslo 1985.
25.
StuderR. K.WelchD. M.SiegelB. A.: Transient alteration of the blood-brain barrier. Effect of hypertonic solutions administered via carotid artery injection. Exp. Neurol.44 (1974), 26.
26.
WaldronR. L.BridenbaughR. B.DampseyE. W.: Effect of angiographic contrast media at cellular level in the brain. Hypertonic vs. chemical action. Amer. J. Roentgenol.122 (1974), 469.
27.
WilcoxJ.EvillC. A.SageM. R.: Effects of intracarotid ionic and non-ionic contrast material on the blood-brain barrier in a rabbit model. Neuroradiology28 (1986), 271.
28.
WilcoxJ.SageM. R.: Is viscosity important in the production of blood-brain barrier disruption by intracarotid contrast media?Neuroradiology26 (1984), 511.
29.
WilcoxJ.EvillC. A.: Effect of intravenous contrast material on the integrity of the blood-brain barrier. Experimental study. Amer. J. Neuroradiol.5 (1984), 41.
